Review



retrovirus vector pretrox  (TaKaRa)


Bioz Verified Symbol TaKaRa is a verified supplier
Bioz Manufacturer Symbol TaKaRa manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    TaKaRa retrovirus vector pretrox
    Figure 1. The secretion from ferroptotic fibroblasts by BACH1 re-expression activates the proliferation and suppresses the expression of SASP in other cells (A–H) The control or Tet-ON BACH1 genes were introduced into Bach1/ iMEFs using <t>retrovirus</t> vectors. 2-ME was removed by culture medium exchange. The culture supernatant from the iMEFs (control: control supernatant, Tet-ON BACH1: ferroptotic supernatant) treated with Dox for 48 h was transferred into Hepa1 cells. The Hepa1 cells were analyzed after treatment with the control or ferroptotic supernatant for 2 (G and H), 3 (F; Figures 2B–2D, 2G, and 2H), or 4 (B–E; Figure 2A) days. (A) Experimental design. (B) GO analysis of the Hepa1 cells. (C) Gene set enrichment analysis of the gene sets related to cell cycle and cytokine expression in the Hepa1 cells. (D) Heatmap displaying the RNA-seq results (counts per million mapped reads) of arbitrarily selected p53 signaling pathway-related genes (KEGG pathway, hsa04115) in the Hepa1 cells. The p values and log2FC (fold change) were calculated using differential expression analysis on edgeR. Cont.: control supernatant, Ferr.: ferroptotic supernatant.
    Retrovirus Vector Pretrox, supplied by TaKaRa, used in various techniques. Bioz Stars score: 96/100, based on 24 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/retrovirus+vector+pretrox/pRetro-Lib+Vector/pm38943639-277-17-20
    Average 96 stars, based on 24 article reviews
    retrovirus vector pretrox - by Bioz Stars, 2026-10
    96/100 stars

    Images

    1) Product Images from "BACH1 inhibits senescence, obesity, and short lifespan by ferroptotic FGF21 secretion."

    Article Title: BACH1 inhibits senescence, obesity, and short lifespan by ferroptotic FGF21 secretion.

    Journal: Cell reports

    doi: 10.1016/j.celrep.2024.114403

    Figure 1. The secretion from ferroptotic fibroblasts by BACH1 re-expression activates the proliferation and suppresses the expression of SASP in other cells (A–H) The control or Tet-ON BACH1 genes were introduced into Bach1/ iMEFs using retrovirus vectors. 2-ME was removed by culture medium exchange. The culture supernatant from the iMEFs (control: control supernatant, Tet-ON BACH1: ferroptotic supernatant) treated with Dox for 48 h was transferred into Hepa1 cells. The Hepa1 cells were analyzed after treatment with the control or ferroptotic supernatant for 2 (G and H), 3 (F; Figures 2B–2D, 2G, and 2H), or 4 (B–E; Figure 2A) days. (A) Experimental design. (B) GO analysis of the Hepa1 cells. (C) Gene set enrichment analysis of the gene sets related to cell cycle and cytokine expression in the Hepa1 cells. (D) Heatmap displaying the RNA-seq results (counts per million mapped reads) of arbitrarily selected p53 signaling pathway-related genes (KEGG pathway, hsa04115) in the Hepa1 cells. The p values and log2FC (fold change) were calculated using differential expression analysis on edgeR. Cont.: control supernatant, Ferr.: ferroptotic supernatant.
    Figure Legend Snippet: Figure 1. The secretion from ferroptotic fibroblasts by BACH1 re-expression activates the proliferation and suppresses the expression of SASP in other cells (A–H) The control or Tet-ON BACH1 genes were introduced into Bach1/ iMEFs using retrovirus vectors. 2-ME was removed by culture medium exchange. The culture supernatant from the iMEFs (control: control supernatant, Tet-ON BACH1: ferroptotic supernatant) treated with Dox for 48 h was transferred into Hepa1 cells. The Hepa1 cells were analyzed after treatment with the control or ferroptotic supernatant for 2 (G and H), 3 (F; Figures 2B–2D, 2G, and 2H), or 4 (B–E; Figure 2A) days. (A) Experimental design. (B) GO analysis of the Hepa1 cells. (C) Gene set enrichment analysis of the gene sets related to cell cycle and cytokine expression in the Hepa1 cells. (D) Heatmap displaying the RNA-seq results (counts per million mapped reads) of arbitrarily selected p53 signaling pathway-related genes (KEGG pathway, hsa04115) in the Hepa1 cells. The p values and log2FC (fold change) were calculated using differential expression analysis on edgeR. Cont.: control supernatant, Ferr.: ferroptotic supernatant.

    Techniques Used: Expressing, Control, RNA Sequencing, Quantitative Proteomics

    Figure 2. The secretion from ferroptotic fibroblasts by BACH1 re-expression suppresses senescence in other cells (A–D, G, and H) The control or Tet-ON BACH1 genes were introduced into Bach1/ iMEFs using retrovirus vectors, and Hepa1 cells were treated with the culture supernatant from the iMEFs as in Figure 1A.
    Figure Legend Snippet: Figure 2. The secretion from ferroptotic fibroblasts by BACH1 re-expression suppresses senescence in other cells (A–D, G, and H) The control or Tet-ON BACH1 genes were introduced into Bach1/ iMEFs using retrovirus vectors, and Hepa1 cells were treated with the culture supernatant from the iMEFs as in Figure 1A.

    Techniques Used: Expressing, Control

    Related Articles

    Plasmid Preparation:

    Article Title: BACH1 inhibits senescence, obesity, and short lifespan by ferroptotic FGF21 secretion.
    Article Snippet: After infection with the rtTA expression vector, the cells were cultured using Tet-free FBS (Cat#: 631101, Takara Bio) instead of the aforementioned FBS. .. To overexpress the mouse FGF21 protein using the Tet-ON system, retrovirus particles were prepared by transfecting the retrovirus vector pRetroX-Tight-Pur (Takara Bio), into which the coding region of the mouse Fgf21 gene had been inserted into the multi-cloning site, into Plat-E cells using FuGENE HD (E2311, Promega). .. As a control, an empty pRetroX-Tight-Pur (Takara Bio) was used instead of the one that Fgf21 was inserted.



    Similar Products

    96
    TaKaRa retrovirus vector pretrox
    Figure 1. The secretion from ferroptotic fibroblasts by BACH1 re-expression activates the proliferation and suppresses the expression of SASP in other cells (A–H) The control or Tet-ON BACH1 genes were introduced into Bach1/ iMEFs using <t>retrovirus</t> vectors. 2-ME was removed by culture medium exchange. The culture supernatant from the iMEFs (control: control supernatant, Tet-ON BACH1: ferroptotic supernatant) treated with Dox for 48 h was transferred into Hepa1 cells. The Hepa1 cells were analyzed after treatment with the control or ferroptotic supernatant for 2 (G and H), 3 (F; Figures 2B–2D, 2G, and 2H), or 4 (B–E; Figure 2A) days. (A) Experimental design. (B) GO analysis of the Hepa1 cells. (C) Gene set enrichment analysis of the gene sets related to cell cycle and cytokine expression in the Hepa1 cells. (D) Heatmap displaying the RNA-seq results (counts per million mapped reads) of arbitrarily selected p53 signaling pathway-related genes (KEGG pathway, hsa04115) in the Hepa1 cells. The p values and log2FC (fold change) were calculated using differential expression analysis on edgeR. Cont.: control supernatant, Ferr.: ferroptotic supernatant.
    Retrovirus Vector Pretrox, supplied by TaKaRa, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/retrovirus+vector+pretrox/pRetro-Lib+Vector/pm38943639-277-17-20
    Average 96 stars, based on 1 article reviews
    retrovirus vector pretrox - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    94
    TaKaRa retrovirus pretrox ires zsgreen1
    Figure 1. The secretion from ferroptotic fibroblasts by BACH1 re-expression activates the proliferation and suppresses the expression of SASP in other cells (A–H) The control or Tet-ON BACH1 genes were introduced into Bach1/ iMEFs using <t>retrovirus</t> vectors. 2-ME was removed by culture medium exchange. The culture supernatant from the iMEFs (control: control supernatant, Tet-ON BACH1: ferroptotic supernatant) treated with Dox for 48 h was transferred into Hepa1 cells. The Hepa1 cells were analyzed after treatment with the control or ferroptotic supernatant for 2 (G and H), 3 (F; Figures 2B–2D, 2G, and 2H), or 4 (B–E; Figure 2A) days. (A) Experimental design. (B) GO analysis of the Hepa1 cells. (C) Gene set enrichment analysis of the gene sets related to cell cycle and cytokine expression in the Hepa1 cells. (D) Heatmap displaying the RNA-seq results (counts per million mapped reads) of arbitrarily selected p53 signaling pathway-related genes (KEGG pathway, hsa04115) in the Hepa1 cells. The p values and log2FC (fold change) were calculated using differential expression analysis on edgeR. Cont.: control supernatant, Ferr.: ferroptotic supernatant.
    Retrovirus Pretrox Ires Zsgreen1, supplied by TaKaRa, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/retrovirus+vector+pretrox/pRetroX-IRES-ZsGreen1+Vector/pmc09829245-574-4-10
    Average 94 stars, based on 1 article reviews
    retrovirus pretrox ires zsgreen1 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    96
    TaKaRa pretrox tight pur retrovirus vector
    Correlation between the tumorigenicity and protein kinase B (AKT) activation of ST 1 cells. (a) Western blot showing the exogenously expressed constitutively active form of AKT ( CA ‐ AKT ). Cells were first transduced with pR etroX‐Tet‐On Advanced <t>retrovirus</t> vector and then with control pR etroX‐Tight‐Pur ( pT ight) or a CA ‐ AKT coding retrovirus vector. The cells were cultured with (+) or without (−) doxycycline (Dox) and analyzed by Western blot. The immunoblot was probed with an antibody to S473‐phosphorylated AKT ( pAKT ) or total AKT . Exogenously expressed CA ‐ AKT (Exo) and endogenous AKT (Endo) are indicated. (b) Western blot analysis of the developed tumors. Control ST 1 cells (No) or the retrovirus‐transduced cells described in (a) were injected into NOG mice, and the developed tumors were analyzed by Western blot. The blot probed with an anti‐hemagglutinin antibody ( HA ) showed the expression of CA ‐ AKT . (c) Tumor growth of control ( pT ight) or CA ‐ AKT vector‐transduced ST 1 cells. Results from six injection sites were averaged. * P < 0.05. (d) Tumor growth by ST 1‐N6 cells in NOG mice treated with the AKT inhibitor MK ‐2206 or control vehicle (30% Captisol). Data shown are representative of two independent experiments. * P < 0.05.
    Pretrox Tight Pur Retrovirus Vector, supplied by TaKaRa, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/retrovirus+vector+pretrox/pRetro-Lib+Vector/pmc04970830-27-41-44
    Average 96 stars, based on 1 article reviews
    pretrox tight pur retrovirus vector - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    94
    TaKaRa retrovirus vector pretrox ires zsgreen1 plasmid dna
    Correlation between the tumorigenicity and protein kinase B (AKT) activation of ST 1 cells. (a) Western blot showing the exogenously expressed constitutively active form of AKT ( CA ‐ AKT ). Cells were first transduced with pR etroX‐Tet‐On Advanced <t>retrovirus</t> vector and then with control pR etroX‐Tight‐Pur ( pT ight) or a CA ‐ AKT coding retrovirus vector. The cells were cultured with (+) or without (−) doxycycline (Dox) and analyzed by Western blot. The immunoblot was probed with an antibody to S473‐phosphorylated AKT ( pAKT ) or total AKT . Exogenously expressed CA ‐ AKT (Exo) and endogenous AKT (Endo) are indicated. (b) Western blot analysis of the developed tumors. Control ST 1 cells (No) or the retrovirus‐transduced cells described in (a) were injected into NOG mice, and the developed tumors were analyzed by Western blot. The blot probed with an anti‐hemagglutinin antibody ( HA ) showed the expression of CA ‐ AKT . (c) Tumor growth of control ( pT ight) or CA ‐ AKT vector‐transduced ST 1 cells. Results from six injection sites were averaged. * P < 0.05. (d) Tumor growth by ST 1‐N6 cells in NOG mice treated with the AKT inhibitor MK ‐2206 or control vehicle (30% Captisol). Data shown are representative of two independent experiments. * P < 0.05.
    Retrovirus Vector Pretrox Ires Zsgreen1 Plasmid Dna, supplied by TaKaRa, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/retrovirus+vector+pretrox/pRetroX-IRES-ZsGreen1+Vector/pm24764126-105-5-10
    Average 94 stars, based on 1 article reviews
    retrovirus vector pretrox ires zsgreen1 plasmid dna - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    TaKaRa pretrox ires zsgreen1 retrovirus vector plasmid dna
    Correlation between the tumorigenicity and protein kinase B (AKT) activation of ST 1 cells. (a) Western blot showing the exogenously expressed constitutively active form of AKT ( CA ‐ AKT ). Cells were first transduced with pR etroX‐Tet‐On Advanced <t>retrovirus</t> vector and then with control pR etroX‐Tight‐Pur ( pT ight) or a CA ‐ AKT coding retrovirus vector. The cells were cultured with (+) or without (−) doxycycline (Dox) and analyzed by Western blot. The immunoblot was probed with an antibody to S473‐phosphorylated AKT ( pAKT ) or total AKT . Exogenously expressed CA ‐ AKT (Exo) and endogenous AKT (Endo) are indicated. (b) Western blot analysis of the developed tumors. Control ST 1 cells (No) or the retrovirus‐transduced cells described in (a) were injected into NOG mice, and the developed tumors were analyzed by Western blot. The blot probed with an anti‐hemagglutinin antibody ( HA ) showed the expression of CA ‐ AKT . (c) Tumor growth of control ( pT ight) or CA ‐ AKT vector‐transduced ST 1 cells. Results from six injection sites were averaged. * P < 0.05. (d) Tumor growth by ST 1‐N6 cells in NOG mice treated with the AKT inhibitor MK ‐2206 or control vehicle (30% Captisol). Data shown are representative of two independent experiments. * P < 0.05.
    Pretrox Ires Zsgreen1 Retrovirus Vector Plasmid Dna, supplied by TaKaRa, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/retrovirus+vector+pretrox/pRetroX-IRES-ZsGreen1+Vector/pm24764126-98-25-30
    Average 94 stars, based on 1 article reviews
    pretrox ires zsgreen1 retrovirus vector plasmid dna - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    Image Search Results


    Figure 1. The secretion from ferroptotic fibroblasts by BACH1 re-expression activates the proliferation and suppresses the expression of SASP in other cells (A–H) The control or Tet-ON BACH1 genes were introduced into Bach1/ iMEFs using retrovirus vectors. 2-ME was removed by culture medium exchange. The culture supernatant from the iMEFs (control: control supernatant, Tet-ON BACH1: ferroptotic supernatant) treated with Dox for 48 h was transferred into Hepa1 cells. The Hepa1 cells were analyzed after treatment with the control or ferroptotic supernatant for 2 (G and H), 3 (F; Figures 2B–2D, 2G, and 2H), or 4 (B–E; Figure 2A) days. (A) Experimental design. (B) GO analysis of the Hepa1 cells. (C) Gene set enrichment analysis of the gene sets related to cell cycle and cytokine expression in the Hepa1 cells. (D) Heatmap displaying the RNA-seq results (counts per million mapped reads) of arbitrarily selected p53 signaling pathway-related genes (KEGG pathway, hsa04115) in the Hepa1 cells. The p values and log2FC (fold change) were calculated using differential expression analysis on edgeR. Cont.: control supernatant, Ferr.: ferroptotic supernatant.

    Journal: Cell reports

    Article Title: BACH1 inhibits senescence, obesity, and short lifespan by ferroptotic FGF21 secretion.

    doi: 10.1016/j.celrep.2024.114403

    Figure Lengend Snippet: Figure 1. The secretion from ferroptotic fibroblasts by BACH1 re-expression activates the proliferation and suppresses the expression of SASP in other cells (A–H) The control or Tet-ON BACH1 genes were introduced into Bach1/ iMEFs using retrovirus vectors. 2-ME was removed by culture medium exchange. The culture supernatant from the iMEFs (control: control supernatant, Tet-ON BACH1: ferroptotic supernatant) treated with Dox for 48 h was transferred into Hepa1 cells. The Hepa1 cells were analyzed after treatment with the control or ferroptotic supernatant for 2 (G and H), 3 (F; Figures 2B–2D, 2G, and 2H), or 4 (B–E; Figure 2A) days. (A) Experimental design. (B) GO analysis of the Hepa1 cells. (C) Gene set enrichment analysis of the gene sets related to cell cycle and cytokine expression in the Hepa1 cells. (D) Heatmap displaying the RNA-seq results (counts per million mapped reads) of arbitrarily selected p53 signaling pathway-related genes (KEGG pathway, hsa04115) in the Hepa1 cells. The p values and log2FC (fold change) were calculated using differential expression analysis on edgeR. Cont.: control supernatant, Ferr.: ferroptotic supernatant.

    Article Snippet: To overexpress the mouse FGF21 protein using the Tet-ON system, retrovirus particles were prepared by transfecting the retrovirus vector pRetroX-Tight-Pur (Takara Bio), into which the coding region of the mouse Fgf21 gene had been inserted into the multi-cloning site, into Plat-E cells using FuGENE HD (E2311, Promega).

    Techniques: Expressing, Control, RNA Sequencing, Quantitative Proteomics

    Figure 2. The secretion from ferroptotic fibroblasts by BACH1 re-expression suppresses senescence in other cells (A–D, G, and H) The control or Tet-ON BACH1 genes were introduced into Bach1/ iMEFs using retrovirus vectors, and Hepa1 cells were treated with the culture supernatant from the iMEFs as in Figure 1A.

    Journal: Cell reports

    Article Title: BACH1 inhibits senescence, obesity, and short lifespan by ferroptotic FGF21 secretion.

    doi: 10.1016/j.celrep.2024.114403

    Figure Lengend Snippet: Figure 2. The secretion from ferroptotic fibroblasts by BACH1 re-expression suppresses senescence in other cells (A–D, G, and H) The control or Tet-ON BACH1 genes were introduced into Bach1/ iMEFs using retrovirus vectors, and Hepa1 cells were treated with the culture supernatant from the iMEFs as in Figure 1A.

    Article Snippet: To overexpress the mouse FGF21 protein using the Tet-ON system, retrovirus particles were prepared by transfecting the retrovirus vector pRetroX-Tight-Pur (Takara Bio), into which the coding region of the mouse Fgf21 gene had been inserted into the multi-cloning site, into Plat-E cells using FuGENE HD (E2311, Promega).

    Techniques: Expressing, Control

    Correlation between the tumorigenicity and protein kinase B (AKT) activation of ST 1 cells. (a) Western blot showing the exogenously expressed constitutively active form of AKT ( CA ‐ AKT ). Cells were first transduced with pR etroX‐Tet‐On Advanced retrovirus vector and then with control pR etroX‐Tight‐Pur ( pT ight) or a CA ‐ AKT coding retrovirus vector. The cells were cultured with (+) or without (−) doxycycline (Dox) and analyzed by Western blot. The immunoblot was probed with an antibody to S473‐phosphorylated AKT ( pAKT ) or total AKT . Exogenously expressed CA ‐ AKT (Exo) and endogenous AKT (Endo) are indicated. (b) Western blot analysis of the developed tumors. Control ST 1 cells (No) or the retrovirus‐transduced cells described in (a) were injected into NOG mice, and the developed tumors were analyzed by Western blot. The blot probed with an anti‐hemagglutinin antibody ( HA ) showed the expression of CA ‐ AKT . (c) Tumor growth of control ( pT ight) or CA ‐ AKT vector‐transduced ST 1 cells. Results from six injection sites were averaged. * P < 0.05. (d) Tumor growth by ST 1‐N6 cells in NOG mice treated with the AKT inhibitor MK ‐2206 or control vehicle (30% Captisol). Data shown are representative of two independent experiments. * P < 0.05.

    Journal: Cancer Science

    Article Title: Xenotransplantation elicits salient tumorigenicity of adult T‐cell leukemia‐derived cells via aberrant AKT activation

    doi: 10.1111/cas.12921

    Figure Lengend Snippet: Correlation between the tumorigenicity and protein kinase B (AKT) activation of ST 1 cells. (a) Western blot showing the exogenously expressed constitutively active form of AKT ( CA ‐ AKT ). Cells were first transduced with pR etroX‐Tet‐On Advanced retrovirus vector and then with control pR etroX‐Tight‐Pur ( pT ight) or a CA ‐ AKT coding retrovirus vector. The cells were cultured with (+) or without (−) doxycycline (Dox) and analyzed by Western blot. The immunoblot was probed with an antibody to S473‐phosphorylated AKT ( pAKT ) or total AKT . Exogenously expressed CA ‐ AKT (Exo) and endogenous AKT (Endo) are indicated. (b) Western blot analysis of the developed tumors. Control ST 1 cells (No) or the retrovirus‐transduced cells described in (a) were injected into NOG mice, and the developed tumors were analyzed by Western blot. The blot probed with an anti‐hemagglutinin antibody ( HA ) showed the expression of CA ‐ AKT . (c) Tumor growth of control ( pT ight) or CA ‐ AKT vector‐transduced ST 1 cells. Results from six injection sites were averaged. * P < 0.05. (d) Tumor growth by ST 1‐N6 cells in NOG mice treated with the AKT inhibitor MK ‐2206 or control vehicle (30% Captisol). Data shown are representative of two independent experiments. * P < 0.05.

    Article Snippet: To construct an expression vector for HA‐tagged CA‐AKT, the insert sequence of pLNCX‐Myr‐HA‐Akt (Addgene) was amplified using KOD FX polymerase (Toyobo, Osaka, Japan) following the manufacturer's recommendation, with primers 5′‐CTGAATTCCACCATGGGGTCTTCAAAATCTAAAC‐3′ and 5′‐CTGAATTCTCAGGCCGTGCCGCTGGCCGAGT‐3′ and subcloned into the Eco RI site of the pRetroX‐Tight‐Pur retrovirus vector (Clontech, Palo Alto, CA, USA) using a ligation kit (TaKaRa Bio, Ohtsu, Japan).

    Techniques: Activation Assay, Western Blot, Transduction, Plasmid Preparation, Cell Culture, Injection, Expressing